Logo image of IOR

INCOME OPP REALTY INVESTORS (IOR) Stock Fundamental Analysis

NYSEARCA:IOR - NYSE Arca - US4529261087 - REIT - Currency: USD

17.1  -0.89 (-4.95%)

Fundamental Rating

3

Overall IOR gets a fundamental rating of 3 out of 10. We evaluated IOR against 101 industry peers in the Financial Services industry. While IOR has a great health rating, there are worries on its profitability. IOR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

IOR had positive earnings in the past year.
IOR had a positive operating cash flow in the past year.
IOR had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: IOR reported negative operating cash flow in multiple years.
IOR Yearly Net Income VS EBIT VS OCF VS FCFIOR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

IOR has a better Return On Assets (4.98%) than 77.23% of its industry peers.
IOR has a Return On Equity of 4.98%. This is in the lower half of the industry: IOR underperforms 60.40% of its industry peers.
Industry RankSector Rank
ROA 4.98%
ROE 4.98%
ROIC N/A
ROA(3y)4.26%
ROA(5y)4.19%
ROE(3y)4.26%
ROE(5y)4.19%
ROIC(3y)N/A
ROIC(5y)N/A
IOR Yearly ROA, ROE, ROICIOR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 4 6 8

1.3 Margins

IOR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IOR Yearly Profit, Operating, Gross MarginsIOR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

9

2. Health

2.1 Basic Checks

The number of shares outstanding for IOR has been reduced compared to 1 year ago.
The number of shares outstanding for IOR has been reduced compared to 5 years ago.
IOR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IOR Yearly Shares OutstandingIOR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
IOR Yearly Total Debt VS Total AssetsIOR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 13921.18 indicates that IOR is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 13921.18, IOR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
There is no outstanding debt for IOR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 13921.18
ROIC/WACCN/A
WACCN/A
IOR Yearly LT Debt VS Equity VS FCFIOR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 36502.33 indicates that IOR has no problem at all paying its short term obligations.
With an excellent Current ratio value of 36502.33, IOR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
IOR has a Quick Ratio of 36502.33. This indicates that IOR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 36502.33, IOR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 36502.33
Quick Ratio 36502.33
IOR Yearly Current Assets VS Current LiabilitesIOR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

IOR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.87%.
IOR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.11% yearly.
EPS 1Y (TTM)5.87%
EPS 3Y18.53%
EPS 5Y-3.11%
EPS Q2Q%-24.53%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IOR Yearly Revenue VS EstimatesIOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
IOR Yearly EPS VS EstimatesIOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.71, which indicates a very decent valuation of IOR.
Compared to the rest of the industry, the Price/Earnings ratio of IOR indicates a somewhat cheap valuation: IOR is cheaper than 62.38% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of IOR to the average of the S&P500 Index (29.63), we can say IOR is valued rather cheaply.
Industry RankSector Rank
PE 11.71
Fwd PE N/A
IOR Price Earnings VS Forward Price EarningsIOR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

IOR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 41.4
EV/EBITDA N/A
IOR Per share dataIOR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INCOME OPP REALTY INVESTORS

NYSEARCA:IOR (2/21/2025, 8:04:00 PM)

17.1

-0.89 (-4.95%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-20 2025-03-20
Inst Owners0.33%
Inst Owner Change-16.83%
Ins OwnersN/A
Ins Owner Change0.64%
Market Cap69.60M
Analysts0
Price TargetN/A
Short Float %0.46%
Short Ratio0.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.71
Fwd PE N/A
P/S N/A
P/FCF 41.4
P/OCF 41.4
P/B 0.58
P/tB 0.58
EV/EBITDA N/A
EPS(TTM)1.46
EY8.54%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.41
FCFY2.42%
OCF(TTM)0.41
OCFY2.42%
SpS0
BVpS29.68
TBVpS29.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.98%
ROE 4.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)4.26%
ROA(5y)4.19%
ROE(3y)4.26%
ROE(5y)4.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 27.96%
Current Ratio 36502.33
Quick Ratio 36502.33
Altman-Z 13921.18
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.87%
EPS 3Y18.53%
EPS 5Y-3.11%
EPS Q2Q%-24.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y82.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3Y-39.11%
FCF growth 5Y-9.8%
OCF growth 1YN/A
OCF growth 3Y-39.11%
OCF growth 5Y-9.8%